Tag: Biogen

Biogen scoops sixth Prix Galien award with UK for life-changing rare...

Biogen was announced as the winner of the Orphan Product Award at last night’s UK Prix Galien 2018, for Spinraza, which in 2017 became...
NURTURE

New data show Spinraza beneficial in the treatment of spinal muscular...

Rates of survival are higher, and respiratory intervention rates are lower, in 25 infants with presymptomatic 5q spinal muscular atrophy (SMA) treated with Spinraza...
NURTURE

NICE draft guidance ‘minded no’ for access to Spinraza for SMA...

UK’s National Institute for Health and Care Excellence (NICE) has published its Appraisal Consultation Document (ACD) outlining a ‘minded no’ for the routine funding...
NURTURE

Spinal Muscular Atrophy drug may be effective if started later than...

Nusinersen (Biogen) has previously been shown to be effective in the treatment of spinal muscular atrophy in infants under seven months of age; recent...

First spinal muscular atrophy treatment to be submitted for US FDA...

Nusinersen, an investigational treatment, has been shown to significantly improve achievement of motor milestones in babies with infantile-onset spinal muscular atrophy, according to an...